Prestige Consumer Healthcare (PBH) Assets (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Assets came in at $3.5 billion in Q4 2025, up 4.96% year-on-year from $3.3 billion in Q4 2024, and up 1.52% quarter-over-quarter from $3.4 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Assets (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Assets history runs 15 years deep, the most recent figure standing at $3.5 billion for Q4 2025.
- On a quarterly basis, Assets rose 4.96% year-over-year to $3.5 billion in Q4 2025; TTM through Dec 2025 was $3.5 billion, a 4.96% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, up 2.53% from the prior year.
- Assets advanced to $3.5 billion in Q4 2025 per PBH's latest filing, from $3.4 billion in the prior quarter.
- Across five years, Assets topped out at $3.7 billion in Q4 2022 and bottomed at $3.3 billion in Q2 2024.
- The 5-year median for Assets is $3.4 billion (2021), against an average of $3.5 billion.
- Across the five-year window, Assets advanced 7.04% in 2022 and retreated 10.93% in 2023, its largest moves.
- Year by year, Assets stood at $3.7 billion in 2021, then increased by 2.47% to $3.7 billion in 2022, then dropped by 10.93% to $3.3 billion in 2023, then decreased by 0.31% to $3.3 billion in 2024, then gained by 4.96% to $3.5 billion in 2025.
- Per Business Quant, the three latest PBH Assets figures stand at $3.5 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.4 billion (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 3.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.49 Bn |
| Sep 30, 2025 | 3.44 Bn |
| Jun 30, 2025 | 3.43 Bn |
| Mar 31, 2025 | 3.40 Bn |
| Dec 31, 2024 | 3.33 Bn |
| Sep 30, 2024 | 3.32 Bn |
| Jun 30, 2024 | 3.31 Bn |
| Mar 31, 2024 | 3.32 Bn |
| Dec 31, 2023 | 3.34 Bn |
| Sep 30, 2023 | 3.33 Bn |
| Jun 30, 2023 | 3.35 Bn |
| Mar 31, 2023 | 3.35 Bn |
| Dec 31, 2022 | 3.75 Bn |
| Sep 30, 2022 | 3.68 Bn |
| Jun 30, 2022 | 3.68 Bn |
| Mar 31, 2022 | 3.67 Bn |
| Dec 31, 2021 | 3.66 Bn |
| Sep 30, 2021 | 3.68 Bn |
| Jun 30, 2021 | 3.56 Bn |
| Mar 31, 2021 | 3.43 Bn |